Skip to main content

Clinical Research concept.

Other Initiatives

COVID-19 Research

Support for COVID-19 Research

The NIH Common Fund received $30 Million from the Coronavirus Aid, Relief, and Economic Security (CARES) Act, 2020 to prevent, prepare for, and respond to coronavirus, domestically or internationally. The Office of Strategic Coordination (OSC), which manages the Common Fund is using these funds to stimulate innovative research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the disease it causes, Coronavirus Disease 2019 (COVID-19). OSC issued immediate funding opportunities in Fiscal Year 2020 for active Common Fund researchers to conduct SARS-CoV-2 and COVID-19 research. Awards issued through these funding opportunities are listed below.

Helpful Links

Future Research Funding Opportunities

In future years, OSC will use CARES Act funds allocated to the NIH Common Fund for researchers to develop new research projects starting in Fiscal Year 2021. Continue to check this page for updates on future SARS-CoV-2 and COVID-19 research funding opportunities from the NIH Common Fund.

For a list of funding opportunities from multiple NIH Institutes, Centers, and Offices — including the NIH Common Fund — please visit the COVID-19 page of information for NIH applicants and recipients of NIH funding.

Emergency Competitive Revisions for Research on SARS-COV-2 and COVID-19

In Fiscal Year 2020, the Office of Strategic Coordination (OSC), issued a Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (NOT-RM-20-015) to stimulate innovative research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the disease it causes, Coronavirus Disease 2019 (COVID-19).

OSC issued emergency competitive revisions to Common Fund grants and cooperative agreements to support innovative research on COVID-19 or SARS-CoV-2 in areas of research including behavioral/social science, health disparities, and novel therapeutics, that fits within the mission of an emergency response to provide critical expertise, resources or activities. A list of funded projects is available on the Common Fund Support for COVID-19 funded research section below.

Funded Research

Expand All to search section using Ctrl+F |
NOTICE OF SPECIAL INTEREST (NOSI): NOT-RM-20-015
Notice of Special Interest (NOSI): Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) NOT-RM-20-015
PI NameInstitution NameTitleCommon Fund Program
ASHLEY, EUAN A (contact) 
WHEELER, MATTHEW THOMAS
STANFORD UNIVERSITYStanford MoTrPAC Bioinformatics Center Molecular Transducers of Physical Activity Consortium (MoTrPAC)
BILAL, USAMADREXEL UNIVERSITYThe Health Consequences of Urban ScalingNIH Director's Early Independence Award (EIA)
BRAUN, ROBERT E (contact) 
MURRAY, STEPHEN A 
WHITE, JACQUELINE K 
JACKSON LABORATORYThe Jackson Laboratory Knockout Mouse Production and Phenotyping Project (JAX KOMP2)Knockout Mouse Phenotyping Program (KOMP2)
DEKOSKY, BRANDON JAMESUNIVERSITY OF KANSAS LAWRENCEAntibody Display Libraries for Precision Screening of Antibody Immune Responses to SARS CoV-2NIH Director's Early Independence Award (EIA)
GOLUB, TODD R. (contact) 
SUBRAMANIAN, ARAVIND
BROAD INSTITUTE, INC.Discovering Existing Medicines that Abrogate Cellular Responses to SARS CoV-2 Infection 
SANJANA, NEVILLE NEW YORK GENOME CENTERIn situ functional genomics to understand transcriptional regulationNIH Director's New Innovator Award (NIA)
TULSKY, JAMES A. (contact) 
VOLANDES, ANGELO
DANA-FARBER CANCER INSTA Telehealth Advance Care Planning Intervention for COVID-19 in New York City
ZHANG, HAICHONGWORCESTER POLYTECHNIC INSTITUTERobotic Lung Ultrasound for Triage of COVID-19 Patients in a Resource Limited EnvironmentNIH Director's Early Independence Award (EIA)
2021 NIH Director's Transformative Research Emergency COVID-19 Awards (RFA-RM-20-020)

Due to the public health emergency, the Transformative Research Award and Early Independence Award issued additional funding opportunities for COVID-19-related research on the prevention of, preparation for, or response to coronavirus SARS-CoV-2 using funds provided through the CARES Act.

PI NameInstitution NameTitle
DEB, ARJUN (contact); ARUMUGASWAMI, VAITHILINGARAJA ; GRAEBER, THOMAS G; PELLEGRINI, MATTEOUNIVERSITY OF CALIFORNIA LOS ANGELESMetabolic and Epigenetic Reprogramming of Vital Organs in SARS-CoV-2 Induced Systemic Toxicity
MANCEBO, RICARDOGENENDEAVOR, LLCDevelopment of a Handheld Rapid Air Sensing System to Monitor and Quantify SARS-CoV-2 in Aerosols in Real-Time
RAY, ANIMESH (contact); HERNANDEZ, JENIFFER BERTHAKECK GRADUATE INST OF APPLIED LIFE SCISRapid Response for Pandemics: Single Cell Sequencing and Deep Learning to Predict Antibody Sequences Against an Emerging Antigen
WEINBERGER, LEOR S (contact); RODICK, ROBERTVXBIOSCIENCES, INC.Autonomously Deploying, Co-Evolving SARS-CoV-2 Antiviral: A New Paradigm for Pandemic Prevention
YAKOUB, ABRAAM M (contact); LAZARTIGUES, ERIC D; TSENG, CHIEN-TE KUNIVERSITY OF NORTH DAKOTASARS-CoV-2 Tropism in the Brain and Its Relationship to COVID-19 Pathogenesis

This page last reviewed on August 16, 2024